Open AccessSilver Nanoparticles with Bronchodilators Through Nebulisation to Treat COVID 19 Patients.
Author(s) -
Subhasish Sarkar
Publication year - 2020
Publication title -
journal of current medical research and opinion
Language(s) - English
Resource type - Journals
eISSN - 2589-8779
pISSN - 2589-8760
DOI - 10.15520/jcmro.v3i04.276
Subject(s) - covid-19 , pandemic , virus , virology , drug , medicine , biology , pharmacology , infectious disease (medical specialty) , disease , outbreak
There are no effective antiviral drugs available against the pandemic causing COVID 19 virus. The complex protein - protein interaction between the virus and host is yet to be determined for designing of precise antiviral drugs against corona virus. The pandemic had claimed several thousand lives and had resulted most devastating effects on our mankind. In this scenario a potent drug is needed which will kill the viruses with minimal side effects on human body. Here I propose a novel antiviral therapy for effective killing of COVID19 with minimal side effects.